With new CDC data expressing optimism about the epidemic of sexually transmitted infections (STIs), take a look at the ...

Recent insights shed light onto the most effective diagnostic tools for laryngeal myasthenia gravis (MG), a poorly understood ...

Gene therapies can be life-changing for people, but the high cost plus the burden of treatment remain barriers to access and ...

Presentations at the 2024 Asembia Specialty Pharmacy Summit focused on reshaping specialty pharmacy while keeping patients ...

The median launch prices in the US increased from $29,630 (IQR, $1322-$49,691) for drugs approved in 201 to $84,240 (IQR, ...

Meaningful change thresholds for the EORTC Quality of Life Questionnaire in chronic lymphocytic leukemia (CLL) or small ...

Experts are now urging the inclusion of sickle cell disease in the global health agenda to address disparities in treatment access. From 2000 to 2021, global births of babies with SCD rose by 13.7%, ...

The 6-year mandatory Increasing Organ Transplant Access Model aims to boost kidney transplants and address disparities by ...

Changes in cardiorespiratory fitness from youth to adulthood was associated with colorectal cancer (CRC) incidence risk.

Investigators were seeking clarification on optimal sequencing of the immune checkpoint inhibitor atezolizumab following ...

The US can learn from what other countries are doing well to implement the best programs to improve patient access to care, ...

The approval of Yesintek (ustekinumab-kfce), the sixth biosimilar to reference Stelara, will be used to treat patients with ...